Cambridge BioMarketing bolsters leadership team with new president

 

Cambridge BioMarketing named Ben Beckley as president. He is overseeing agency operations and supporting the firm’s next chapter of transformation, innovation and expansion. Cambridge BioMarketing is an Ashfield company, part of UDG Healthcare plc and a leading rare disease agency worldwide. 

“I am honored to join Cambridge BioMarketing and lead such a tremendous agency,” Beckley says. “As the leader in rare orphan disease marketing and communications, the agency enjoys well-deserved recognition as having the strategy, creativity, digital prowess, and talent to continue innovating alongside pharmaceutical and biotech clients and deliver positive outcomes for patients. I am humbled to have the opportunity to build upon the agency’s legacy and look forward to continued excellence and opportunities for Cambridge.”

Beckley has served in various senior leadership positions throughout his career, including managing director and business lead for the Rare Disease Village at Havas Health & You, senior VP at precisioneffect, and director of marketing communications at medical device manufacturer ConforMIS Inc. He has been part of the executive team at Ashfield since 2018 and previously served as global commercial director of Ashfield Healthcare Communications, overseeing global commercial strategic partnerships, business development, and branding efforts for the firm’s healthcare communications business unit. He is based at Cambridge BioMarketing’s headquarters in Boston.